CSP
HALO icon

Cary Street Partners’s Halozyme HALO Stock Holding History

Cary Street Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Hold
20,445
– – 0.04% 405
2026
Q1 		$1.32M Hold
20,445
– – 0.03% 395
2025
Q4 		$1.38M Sell
20,445
-245
-1% -$16.5K 0.03% 385
2025
Q3 		$1.52M Sell
20,690
-84,291
-80% -$5.6M 0.04% 350
2025
Q2 		$5.46M Sell
104,981
-418
-0.4% -$23.8K 0.15% 155
2025
Q1 		$6.73M Buy
105,399
+6,245
+6% +$363K 0.21% 115
2024
Q4 		$4.74M Buy
+99,154
New +$5.08M 0.15% 140

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Cary Street Partners's HALO Position: Q2 2026 in Review

Cary Street Partners held its Halozyme (HALO) position steady in Q2 2026 at 20,445 shares worth $1.6M. The position accounts for 0.04% of the portfolio, ranked #405.

Cary Street Partners first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.73M in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Cary Street Partners held 20,445 shares of Halozyme worth $1.6M as of Q2 2026.
  • Cary Street Partners left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.04% of Cary Street Partners's portfolio in Q2 2026, its #405 holding.
  • Cary Street Partners first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Halozyme position peaked at $6.73M in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.